These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
178 related items for PubMed ID: 12645018
1. Novel carboranyl C-glycosides for the treatment of cancer by boron neutron capture therapy. Tietze LF, Griesbach U, Schuberth I, Bothe U, Marra A, Dondoni A. Chemistry; 2003 Mar 17; 9(6):1296-302. PubMed ID: 12645018 [Abstract] [Full Text] [Related]
2. Preparation of a new carboranyl lactoside for the treatment of cancer by boron neutron capture therapy: synthesis and toxicity of fluoro carboranyl glycosides for in vivo 19F-NMR spectroscopy. Tietze LF, Bothe U, Schuberth I. Chemistry; 2000 Mar 03; 6(5):836-42. PubMed ID: 10826605 [Abstract] [Full Text] [Related]
3. Promising carboranylquinazolines for boron neutron capture therapy: synthesis, characterization, and in vitro toxicity evaluation. Genady AR. Eur J Med Chem; 2009 Jan 03; 44(1):409-16. PubMed ID: 18407378 [Abstract] [Full Text] [Related]
4. Carboranyl bisglycosides for the treatment of cancer by boron neutron capture therapy. Tietze LF, Bothe U, Griesbach U, Nakaichi M, Hasegawa T, Nakamura H, Yamamoto Y. Chembiochem; 2001 May 04; 2(5):326-34. PubMed ID: 11828461 [Abstract] [Full Text] [Related]
5. Synthesis of new boron-rich building blocks for boron neutron capture therapy or energy-filtering transmission electron microscopy. Raddatz S, Marcello M, Kliem HC, Tröster H, Trendelenburg MF, Oeser T, Granzow C, Wiessler M. Chembiochem; 2004 Apr 02; 5(4):474-82. PubMed ID: 15185371 [Abstract] [Full Text] [Related]
7. Synthesis of functionalized carboranes as potential anticancer and BNCT agents. Reddy VJ, Roforth MM, Tan C, Reddy MV. Inorg Chem; 2007 Jan 22; 46(2):381-3. PubMed ID: 17279815 [Abstract] [Full Text] [Related]
8. Boron analysis and boron imaging in biological materials for Boron Neutron Capture Therapy (BNCT). Wittig A, Michel J, Moss RL, Stecher-Rasmussen F, Arlinghaus HF, Bendel P, Mauri PL, Altieri S, Hilger R, Salvadori PA, Menichetti L, Zamenhof R, Sauerwein WA. Crit Rev Oncol Hematol; 2008 Oct 22; 68(1):66-90. PubMed ID: 18439836 [Abstract] [Full Text] [Related]
9. Ortho-carboranyl glycosides for the treatment of cancer by boron neutron capture therapy. Tietze LF, Bothe U, Griesbach U, Nakaichi M, Hasegawa T, Nakamura H, Yamamoto Y. Bioorg Med Chem; 2001 Jul 22; 9(7):1747-52. PubMed ID: 11425576 [Abstract] [Full Text] [Related]
10. Synthesis, Molecular Docking, and In Vitro Boron Neutron Capture Therapy Assay of Carboranyl Sinomenine. Cai J, Hosmane NS, Takagaki M, Zhu Y. Molecules; 2020 Oct 14; 25(20):. PubMed ID: 33066470 [Abstract] [Full Text] [Related]
11. Synthesis and antitumor activity of new shikonin glycosides. Su Y, Xie J, Wang Y, Hu X, Lin X. Eur J Med Chem; 2010 Jul 14; 45(7):2713-8. PubMed ID: 20403646 [Abstract] [Full Text] [Related]
12. Synthesis of indirubin-N'-glycosides and their anti-proliferative activity against human cancer cell lines. Libnow S, Methling K, Hein M, Michalik D, Harms M, Wende K, Flemming A, Köckerling M, Reinke H, Bednarski PJ, Lalk M, Langer P. Bioorg Med Chem; 2008 May 15; 16(10):5570-83. PubMed ID: 18434163 [Abstract] [Full Text] [Related]
13. Efficient synthesis of alpha- and beta-chacotriosyl glycosides using appropriate donors, and their cytotoxic activity. Miyashita H, Kai Y, Nohara T, Ikeda T. Carbohydr Res; 2008 Jun 09; 343(8):1309-15. PubMed ID: 18440498 [Abstract] [Full Text] [Related]
14. Synthesis of furanosyl alpha-C-glycosides derived from 4-chloro-4-deoxy-alpha-D-galactose and their cytotoxic activities. Yan L, Dai GF, Yang JL, Liu FW, Liu HM. Bioorg Med Chem Lett; 2007 Jun 15; 17(12):3454-7. PubMed ID: 17462891 [Abstract] [Full Text] [Related]
15. Synthesis of carboranes containing an azulene framework and in vitro evaluation as boron carriers. Nakamura H, Sekido M, Yamamoto Y. J Med Chem; 1997 Aug 29; 40(18):2825-30. PubMed ID: 9288164 [Abstract] [Full Text] [Related]
16. Hyaluronan as carrier of carboranes for tumor targeting in boron neutron capture therapy. Meo CD, Panza L, Capitani D, Mannina L, Banzato A, Rondina M, Renier D, Rosato A, Crescenzi V. Biomacromolecules; 2007 Feb 29; 8(2):552-9. PubMed ID: 17291079 [Abstract] [Full Text] [Related]
17. Asymmetric synthesis and biological evaluation of glycosidic prodrugs for a selective cancer therapy. Tietze LF, von Hof JM, Krewer B, Müller M, Major F, Schuster HJ, Schuberth I, Alves F. ChemMedChem; 2008 Dec 29; 3(12):1946-55. PubMed ID: 19021160 [Abstract] [Full Text] [Related]
18. Hydrophilically enhanced 3-carboranyl thymidine analogues (3CTAs) for boron neutron capture therapy (BNCT) of cancer. Narayanasamy S, Thirumamagal BT, Johnsamuel J, Byun Y, Al-Madhoun AS, Usova E, Cosquer GY, Yan J, Bandyopadhyaya AK, Tiwari R, Eriksson S, Tjarks W. Bioorg Med Chem; 2006 Oct 15; 14(20):6886-99. PubMed ID: 16831554 [Abstract] [Full Text] [Related]